Cusatuzumab

MedChem Express

Cusatuzumab

10

Research Use Only

Monoclonal

98.80

Cusatuzumab is a human alphaCD70 monoclonal antibody. Cusatuzumab shows cytotoxicity activity with enhanced antibody-dependent cellular. Cusatuzumab reduces leukemia stem cells (LSCs) and triggers gene signatures related to myeloid differentiation and apoptosis. Cusatuzumab has the potential for the research of Acute myeloid leukemia (AML)[1].

-80°C

12352203